Glycemic control and clinical outcomes in patients with diabetes and atrial fibrillation: a nationwide cohort study
Acta Diabetologica · 22.06.2026 · 63 (8) · 1459-1468
DOI: 10.1007/s00592-026-02725-1 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Acta Diabetologica, online erschienen am 22.06.2026. Verfasst von Elis Kouki und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Helsinki, 00270, Helsinki, Finland. elis.kouki@helsinki.fi. Hauptthemen laut MEDLINE: Atrial Fibrillation, Glycemic Control, Diabetes Mellitus. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Helsinki.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
To evaluate the association of HbA1c level at the time of atrial fibrillation (AF) diagnosis with adverse outcomes (death, ischemic stroke (IS), myocardial infarction (MI), bleeding) in an unselected nationwide cohort of patients with AF and diabetes mellitus (DM).
Methods
The retrospective FinACAF registry study covered all patients with incident AF in Finland between 2010 and 2017. Outcomes were analyzed using HRs and sHRs (hazard ratios and subdistribution hazard ratios), with HbA1c modelled both categorically and continuously.
Results
Among 157 658 patients with incident AF, DM was present in 23% (n = 35 872). Baseline HbA1c was available in 49% (17 519) of DM patients. DM was associated with increased hazards of all evaluated outcomes. Elevated HbA1c in categorical analyses was associated with progressively increased adjusted HRs and sHRs, with highest ratios seen in HbA1c > 63 mmol/mol for death (HR 1.56, 95% CI 1.45–1.68), IS (sHR 1.38 95% CI 1.20–1.59), and MI (sHR 1.70 95% CI 1.48–1.94), when compared to patients without DM. In continuous analyses, higher HbA1c levels were associated with increasing hazards for mortality, IS, and MI. Bleeding hazards remained stable across the HbA1c spectrum.
Conclusions
Higher baseline HbA1c levels were associated with progressively increased hazards of mortality, IS, and MI in patients with incident AF and DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Helsinki, 00270, Helsinki, Finland. elis.kouki@helsinki.fi.
- Department of Internal Medicine, Heart Center, Päijät-Häme Central Hospital, Lahti, Finland.
- Heart and Lung Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
- University of Eastern Finland, Kuopio, Finland.
- Heart Centre, Turku University Hospital, and University of Turku, Turku, Finland.
- Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland.
Förderung
- University of Helsinki
Zitieren
APA
Kouki, E., Salmela, B., Aro, A., Halminen, O., Teppo, K., Niskanen, L., Haukka, J., Putaala, J., Linna, M., Mustonen, P., Hartikainen, J., Airaksinen, K. E. J., & Lehto, M. (2026). Glycemic control and clinical outcomes in patients with diabetes and atrial fibrillation: a nationwide cohort study. Acta Diabetologica, 63(8), 1459-1468. https://doi.org/10.1007/s00592-026-02725-1
Vancouver
Kouki E, Salmela B, Aro A, Halminen O, Teppo K, Niskanen L, et al. Glycemic control and clinical outcomes in patients with diabetes and atrial fibrillation: a nationwide cohort study. Acta Diabetologica. 2026;63(8):1459-1468. doi:10.1007/s00592-026-02725-1
BibTeX
@article{Kouki2026,
author = {Kouki, Elis and Salmela, Birgitta and Aro, Aapo and Halminen, Olli and Teppo, Konsta and Niskanen, Leo and Haukka, Jari and Putaala, Jukka and Linna, Miika and Mustonen, Pirjo and Hartikainen, Juha and Airaksinen, K E Juhani and Lehto, Mika},
title = {Glycemic control and clinical outcomes in patients with diabetes and atrial fibrillation: a nationwide cohort study},
journal = {Acta Diabetologica},
year = {2026},
volume = {63},
number = {8},
pages = {1459--1468},
doi = {10.1007/s00592-026-02725-1}
}
EUVIMED